Evidence map›Paper›PMID 30607151›Full record

ArticleResearch in pharmaceutical sciences2018

Anti-melanogenesis and anti-tyrosinase properties of

Samira Eghbali-Feriz, Akram Taleghani, Hadi Al-Najjar, Seyed Ahmad Emami, Homa Rahimi, Javad Asili, Samira Hasanzadeh, Zahra Tayarani-Najaran

Open access · goldAbstract read
In one paragraph

Article in Research in pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Methoxyflavones from Black Ginger (Plants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. The Potential of Purple Waxy Corn Cob (Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Current issues in molecular biology · 2022
    Article
  12. Antioxidant Capacity ofPlants (Basel, Switzerland) · 2022
    Article
  13. Molecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Research in pharmaceutical sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Samira Eghbali-FerizDepartment of Pharmacognosy, School of pharmacy, Mashhad university of Medical Sciences, Mashhad, I.R. Iran.
Akram TaleghaniDepartment of Chemistry, Faculty of Science, University of Birjand, Birjand, I.R. Iran.
Hadi Al-NajjarDepartment of Pharmacy, College of Health Science, Public Authority for Applied Education and Training (PAAET), Kuwait.
Seyed Ahmad EmamiDepartment of Pharmacognosy, School of pharmacy, Mashhad university of Medical Sciences, Mashhad, I.R. Iran.
Homa RahimiMedical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, I.R. Iran.
Javad AsiliDepartment of Pharmacognosy, School of pharmacy, Mashhad university of Medical Sciences, Mashhad, I.R. Iran.
Samira HasanzadehDepartment of Pharmacognosy, School of pharmacy, Mashhad university of Medical Sciences, Mashhad, I.R. Iran.
Zahra Tayarani-NajaranBiotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, I.R. Iran.
Mashhad University of Medical Sciences · IRPublic Authority for Applied Education and Training · KWUniversity of Birjand · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-tyrosinaseMelanogenesisP. atlantica subsp. mutica

Identifiers

PMID30607151
PMCPMC6288995
OpenAlexW2900584147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.